Resistant Hypertension after Hypertensive Intracerebral Hemorrhage Is Associated with More Medical Interventions and Longer Hospital Stays without Affecting Outcome

Frontiers in Neurology
Daojun HongWengui Yu

Abstract

Hypertension (HTN) is the most common cause of spontaneous intracerebral hemorrhage (ICH). The aim of this study is to investigate the role of resistant HTN in patients with ICH. We conducted a retrospective study of all consecutive ICH admissions at our medical center from November 2013 to October 2015. The clinical features of patients with resistant HTN (requiring four or more antihypertensive agents to keep systolic blood pressure <140 mm Hg) were compared with those with responsive HTN (requiring three or fewer agents). Of the 152 patients with hypertensive ICH, 48 (31.6%) had resistant HTN. Resistant HTN was independently associated with higher body mass index and proteinuria. Compared to the responsive group, patients with resistant HTN had higher initial blood pressures and greater requirement for ventilator support, hematoma evacuation, hypertonic saline therapy, and nicardipine infusion. Resistant HTN increases length of stay (LOS) in the intensive care unit (ICU) (4.2 vs 2.1 days; p = 0.007) and in the hospital (11.5 vs 7.0 days; p = 0.003). Multivariate regression analysis showed that the rate of systolic blood pressure >140 mm Hg and duration of nicardipine infusion were independently associated with LOS in the ICU...Continue Reading

References

Nov 1, 1986·Stroke; a Journal of Cerebral Circulation·T BrottV Hertzberg
Jul 1, 1981·Stroke; a Journal of Cerebral Circulation·G J Campbell, M R Roach
Jan 1, 1995·Stroke; a Journal of Cerebral Circulation·B K DandapaniR C Duncan
Aug 1, 1996·Stroke; a Journal of Cerebral Circulation·R U KothariJ Khoury
Dec 31, 1997·Stroke; a Journal of Cerebral Circulation·S KazuiT Yamaguchi
Apr 3, 2001·Stroke; a Journal of Cerebral Circulation·J C HemphillS C Johnston
Sep 18, 2007·Neurocritical Care·Kazuhiro OhwakiAkira Tamura
May 16, 2008·The New England Journal of Medicine·Stephan A MayerUNKNOWN FAST Trial Investigators
Sep 30, 2008·Neurocritical Care·Andrew M NaidechThomas P Bleck
Aug 4, 2012·Stroke; a Journal of Cerebral Circulation·Atte MeretojaTurgut Tatlisumak
Nov 21, 2012·Nature Reviews. Nephrology·Pantelis A SarafidisGeorge L Bakris
Apr 3, 2013·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Maria StepanovaZobair M Younossi
May 30, 2013·The New England Journal of Medicine·Craig S AndersonUNKNOWN INTERACT2 Investigators
Dec 6, 2014·Stroke; a Journal of Cerebral Circulation·Jeffrey J FletcherJames F Burke
Mar 31, 2015·Journal of Intensive Care Medicine·Shaheryar Hafeez, Réza Behrouz
Aug 6, 2015·Stroke; a Journal of Cerebral Circulation·Lisa S ManningThompson G Robinson
Oct 16, 2015·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Claude NguyenSean Savitz
Jun 9, 2016·The New England Journal of Medicine·Adnan I QureshiUNKNOWN ATACH-2 Trial Investigators and the Neurological Emergency Treatment Trials Network

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.